Pediatric Pulmonary Vascular Disease

Therapy in pediatric pulmonary hypertension: memoire of an unfinished journey

Martin Hosking, Angela BatesUniversity of British Columbia. University of Alberta.Canada Canadian Journal of CardiologyCan J Cardiol 2024;DOI: 10.1016/j.cjca.2024.02.009 AbstractAbstract Not Available CategoryMedical Therapy. Efficacy or Lack of Efficacy Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication Article AccessFree PDF File or Full Text Article Available Through […]

Therapy in pediatric pulmonary hypertension: memoire of an unfinished journey Read More »

Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry

Julie Wacker, Tilman Humpl, Rolf M. F. Berger, Dunbar Ivy, David Bowers, Damien Bonnet, Maurice Beghetti on behalf of the TOPP InvestigatorsChildren’s University Hospital and University of Geneva. Hospital for Sick Children and University of Toronto. Beatrix Children’s Hospital, University Medical Center Groningen and University of Groningen. Children’s Hospital Colorado and University of Colorado School

Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry Read More »

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

Dunbar Ivy, Maurice Beghetti, Ernesto Juaneda‑Simian, Ramiya Ravindranath, Mary Ann Lukas, Sandra Machlitt‑Northen, Nicola Scott, Jun Narita, Rolf M. F. BergerChildren’s Hospital Colorado. University Children’s Hospital HUG and University of Geneva. Hospital de Niños de la Santísma Trinidad. Glaxo-Smith-Kline. Osaka University Graduate School of Medicine. Beatrix Children’s Hospital, University Medical Center Groningen and University of

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study Read More »

Increased Elastase and Matrix Metalloproteinase Levels in the Pulmonary Arteries of Infants With Congenital Diaphragmatic Hernia

Jui-Hsia Hung, Stéphanie Langlois, Meagen Weibe, Benjamin Wild, Jessica Barré-Dunn, Kyle N. CowanUniversity of Ottawa and Children’s Hospital of Eastern Ontario. Canada Journal of Pediatric SurgeryJ Pediatr Surg 2024;DOI: 10.1016/j.jpedsurg.2024.01.028 AbstractBackground: Pulmonary vascular disease (PVD) complicated with pulmonary hypertension (PH) is a leading cause of mortality in congenital diaphragmatic hernia (CDH). Unfortunately, CDH patients are often resistant

Increased Elastase and Matrix Metalloproteinase Levels in the Pulmonary Arteries of Infants With Congenital Diaphragmatic Hernia Read More »

Outcome following acute and recurrent rheumatic fever

Suchaya Silvilairat, Artit Sornwai, Saviga Sethasathien, Kwannapas Saengsin, Krit Makonkawkeyoon, Rekwan Sittiwangkul, Yupada PongprotChiang Mai University.Thailand Pediatrics and International Child HealthPediatr Int Child Health 2024;DOI: 10.1080/20469047.2024.2313330 AbstractBackground: Rheumatic carditis is the leading cause of permanent disability caused by damage of the cardiac valve. This study aimed to determine the outcome and predictors of valve surgery in patients

Outcome following acute and recurrent rheumatic fever Read More »

Factors affecting length of stay according to bronchopulmonary dysplasia severity: a nationwide cohort study in Korea

Hye Mi Lee, Jeongmin Shin, Sae Yun Kim, So Young KimThe Catholic University of Korea. Republic of Korea World Journal of PediatricsWorld J Pediatr 2024;DOI: 10.1007/s12519-023-00794-8 AbstractBackground: Longer hospitalizations for preterm infants with bronchopulmonary dysplasia (BPD) delay developmental outcomes, increase the risk for hospital-acquired complications, and exert a substantial socioeconomic burden. This study aimed to identify factors

Factors affecting length of stay according to bronchopulmonary dysplasia severity: a nationwide cohort study in Korea Read More »

[Risks of magistral preparations in pediatrics]

Charlotte Rosen, Caroline Jacqmart, Corinne Charlier, Maurice Beghetti, Marie-Christine SeghayeCentre Hospitalier Universitaire de Liège. Hôpitaux universitaires de Genève.Belgium and Switzerland Revue Medicale de LiegeRev Med Liege 2024; 79: 104-109DOI: Not Available AbstractVasoreactive pulmonary arterial hypertension (PAH) in children is a form of idiopathic PAH that responds to vasoreactive testing with nitric oxide (NO) by a

[Risks of magistral preparations in pediatrics] Read More »

Assessment of pulmonary veins after atrio-pericardial anastomosis by cardiovascular magnetic resonance

Steven C. Greenway, Shi-Joon Yoo, Giedrius Baliulis, Christopher Caldarone, John Coles, Lars Grosse-WortmannHospital for Sick Children and University of Toronto.CanadaJournal of Cardiovascular MagneticResonanceJ Cardiovasc Magn Reson 2011; 13:DOI: 10.1186/1532-429X-13-72 AbstractBackground: The atrio-pericardial anastomosis (APA) uses a pericardial pouch to create a large communication between the left atrium and the pulmonary venous contributaries in order to avoid direct

Assessment of pulmonary veins after atrio-pericardial anastomosis by cardiovascular magnetic resonance Read More »

Computed tomography angiography with three-dimensional reconstruction for pulmony venous definition in high-risk infants with congenital heart disease

Russel Hirsch, William Gottliebson, Eric Crotty, Robert Fleck, Janet StrifeCincinnati Children’s Hospital Medical Center and University of Cincinnati.United States Congenital Heart DiseaseCongenit Heart Dis 2006; 1: 104-110DOI: 10.1111/j.1747-0803.2006.00016.x AbstractBackground: Pulmonary venous anomalies may be difficult to define in small, critically ill infants using standard echocardiography. In many centers, invasive cardiac catheterization is used if the diagnosis remains

Computed tomography angiography with three-dimensional reconstruction for pulmony venous definition in high-risk infants with congenital heart disease Read More »

Mechanism of pulmonary vein stenosis in infants with normally connected veins

Iran M. Sadr, Puay E. Tan, Mark W. Kieran, Kathy J. JenkinsChildren’s Hospital, Boston.United States American Journal of CardiologyAm J Cardiol 2000; 86: 577-579DOI: 10.1016/s0002-9149(00)01022-5 AbstractWe used microscopy, immunohistochemistry, and cell culture to identify the mechanism of restenosis in 4 infants with isolated pulmonary vein stenosis. Recurrent obstruction appears to be due to myofibroblastic proliferation in

Mechanism of pulmonary vein stenosis in infants with normally connected veins Read More »

Scroll to Top